Cell and gene therapies have the potential to accelerate growth of individualized and focused treatments for diseases that cannot be cured by available treatment options and this is expected to further more fuel market development. Harnessing this powerful new engineering, needless to say, will not be easy. Executives must grapple with tricky stra